ScholarIQanswers from OpenAlex

Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures

PaperCitations, authors & open-access status

Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures have?

ScholarIQcitation count

Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures has 20 citations in the OpenAlex counts ScholarIQ stores.

When was Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures published?

ScholarIQyear

Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures has 2014 year in the ScholarIQ index.

What is the open-access status of Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures?

ScholarIQoa status

Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures has closed oa status in the ScholarIQ index.

What is the DOI of Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures?

ScholarIQdoi

The DOI for Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures is on the source record.

What is the PMID of Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures?

ScholarIQpmid

The PMID for Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures is on the source record.

What is the OpenAlex record for Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures?

ScholarIQopenalex

The OpenAlex for Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial